Lobucavir
| Lobucavir | |
|---|---|
| Lobucavir.svg | |
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Lobucavir is an antiviral drug that was developed for the treatment of various viral infections. It is a nucleoside analogue that inhibits viral DNA polymerase, thereby preventing viral replication.
Mechanism of Action[edit]
Lobucavir functions as a nucleoside analogue, which means it mimics the natural building blocks of DNA. When incorporated into viral DNA by the viral DNA polymerase, it causes premature chain termination. This effectively halts the replication of the virus, as the incomplete DNA cannot be used to produce new viral particles.
Development and Clinical Trials[edit]
Lobucavir was initially developed for the treatment of hepatitis B virus (HBV) and herpes simplex virus (HSV) infections. During its development, it showed promise in inhibiting the replication of these viruses in vitro and in early clinical trials.
Hepatitis B Virus[edit]
In studies involving patients with chronic hepatitis B, lobucavir demonstrated a reduction in viral load and improvement in liver function tests. However, further development was halted due to concerns about potential carcinogenicity observed in animal studies.
Herpes Simplex Virus[edit]
Lobucavir was also tested for efficacy against herpes simplex virus infections. It showed activity against both HSV-1 and HSV-2 in laboratory settings. Despite these promising results, the development for this indication was also discontinued.
Chemical Structure[edit]
Lobucavir is a synthetic analogue of the natural nucleoside guanosine. Its chemical structure allows it to be incorporated into viral DNA, where it acts as a chain terminator.
Potential Uses[edit]
Although lobucavir is not currently approved for clinical use, its mechanism of action suggests potential applications in treating other DNA virus infections. Research into similar compounds continues, with the aim of developing safer and more effective antiviral therapies.
Related Pages[edit]
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
